filmov
tv
JNJ Split: Keep Both or Get Rid of One J?
Показать описание
After 59 years of dividend increases, Johnson & Johnson (JNJ) was up for a change! Management decided to split the company. You probably have already heard the news but today we'll see if you should keep the pharma, or the consumer, or both? What does it really mean for you as an investor?
In the comments, what's your take on it?
0:00 About the News
3:05 JNJ Business Model & Growth Vectors
07:24 What's Going to Happen Next
MORE
Get more info on:
Twitter: @TheDividendGuy
Disclaimer: The information contained within this video channel is for informational purposes only, and it is not intended as a recommendation of the securities highlighted or any particular investment strategy; nor should it be considered a solicitation to buy or sell any security. In addition, this information is not represented or warranted to be accurate, correct, complete, or timely. The securities mentioned in this video may not be suitable for all types of investors and the information contained in this video does not constitute advice. Before acting on any information in this email, readers should consider whether such an investment is suitable for their particular circumstances, perform their own due diligence, and if necessary, seek professional advice.
Комментарии